Avricore Health Inc. AVCR.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -198.90K | -149.40K | -676.50K | -275.40K | -331.80K |
| Total Depreciation and Amortization | 6.60K | 11.70K | -400.00 | 32.50K | 30.20K |
| Total Amortization of Deferred Charges | -- | -- | 2.80K | 2.70K | 2.60K |
| Total Other Non-Cash Items | 0.00 | 7.20K | 377.00K | 37.40K | 92.80K |
| Change in Net Operating Assets | -152.30K | 112.00K | 84.40K | -18.80K | -88.50K |
| Cash from Operations | -344.70K | -18.50K | -212.70K | -221.60K | -294.70K |
| Capital Expenditure | -100.00 | -2.10K | -3.00K | -11.40K | -1.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -2.50K | -2.00K | -2.90K |
| Cash from Investing | -100.00 | -2.10K | -5.50K | -13.40K | -4.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.19M | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 859.70K | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -200.00 | 500.00 | 300.00 | 200.00 | -700.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 514.60K | -20.10K | -217.90K | -234.80K | -299.60K |